Advertisement
Advertisement

ATXS

ATXS logo

Astria Therapeutics Inc

9.57
USD
+0.02
+0.21%
Dec 18, 12:16 UTC -5
Open

Astria Therapeutics Inc Profile

About

Astria Therapeutics is a biopharmaceutical company which focuses on therapies to treat allergic and immunological diseases. The company's program include STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Astria Therapeutics, formerly known as Catabasis Pharmaceuticals Inc., is based in BOSTON.

Info & Links

CEO

Jill C. Milne

Headquarters

75 State Street, Suite 1400
Boston, MA 02109, UNITED STATES

Industry

Pharmaceuticals Major

Sector

Health Technology

Website

www.astriatx.com

Auditor

Ernst & Young LLP

Share holders

20

Employees

59

Astria Therapeutics Inc Statistics

Valuation Measures

Market Capitalization2

540.04M

Enterprise Value

459.14M

Enterprise Value/EBITDA(ttm)

-3.95

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

2.18

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-43.58%

Return on Invested Capital(ttm)

-48.13%

Return on Assets(ttm)

-29.36%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-116.17M

Net Income Available to Common(ttm)

-100.04M

Diluted EPS(ttm)

-2.09

Share Statistics

Beta (5Y Monthly)

0.67

52-Week Change

99.79%

S&P 500 52-Week Change

27.98%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

56.43M

Dividend Yield

0.00%

Float4

54.80M

% Held by Insiders

2.90%

% Held by Institutions

98.98%

Balance Sheet

Total Cash(mrq)

344.28M

Total Cash Per Share(mrq)

6.10

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

22.38%

Quick Ratio(mrq)

22.38%

Book Value Per Share(mrq)

4.36

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.10

Free Cash Flow(ytd)

-64.17M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement